Gene signature as cancer treatment tool

Gene signature identifies leukemia patients who should avoid transplants
An international team of researchers led by scientists at Dana-Farber Cancer Institute in Boston have used a gene test to identify certain patients with adult T-cell acute lymphoblastic leukemia (ALL) who can be successfully treated with chemotherapy alone and should not be subjected to the rigors of bone marrow transplants. The researchers will present their data at the annual meeting of the American Society of Hematology in Philadelphia on Dec. 9.

Contact:
Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute

Message posted by: Wouter Kalle